key: cord-0964300-mzrso5r0 authors: Fjaellegaard, Katrine; Petersen, Jesper Koefod; Stamp, Inger Merete; Høegholm, Asbjørn; Clementsen, Paul Frost; Bodtger, Uffe title: Pleural Epithelioid Hemangioendothelioma mimicking pleural empyema: A case report date: 2020-08-18 journal: Respir Med Case Rep DOI: 10.1016/j.rmcr.2020.101194 sha: 646dbceeefbfa21ab228996b5e3ee408242d025e doc_id: 964300 cord_uid: mzrso5r0 Malignant pleural effusion is an important and difficult differential diagnosis to pleural empyema. Epithelioid hemangioendothelioma is an uncommon vascular tumor, which typically occurs in liver, lung or bone. We present an extremely rare case of primary pleural epithelioid hemangioendothelioma mimicking pleural empyema. We conclude, that pleural epithelioid hemangioendothelioma should be kept in mind as a differential diagnosis in patients suspected of empyema. Pleural empyema is an frequent clinical condition with an annual incidence of 10-12 per 100,000 inhabitants (1) . The mortality is approximately 10% [1) . Malignant pleural effusion (MPE) has an incidence of ~70 per 100,000 (1) mostly due to pleural dissemination from extrapleural malignancy, and can present as pleural empyema due to early translocation of bacteria via the damaged pleural lining. We describe a case of primary pleural malignancy presenting as pleural empyema. A 71-year-old man, presented with dyspnea, cough and no effect of oral antibiotics. He was a current smoker with 80 pack-years, stable COPD and metabolic syndrome, and no known exposure to asbestos. Four years earlier, he had been diagnosed with a right-sided, hemorrhagic, exudative pleural effusion presumably caused by a thoracic trauma. The effusion was found to be culture negative and contained no malignant cells. Low-dose chest computed tomography (CT)scan four weeks later showed complete remission of the pleural effusion. At the current admission, chest x-ray showed moderate left sided pleural effusion and blood tests showed elevated leucocyte count (14.7x10 9 /L) and C-reactive protein (CRP) level (170mg/L). The effusion was drained, revealing hemorrhagic pleural fluid. Pleural empyema was suspected, and the patient was treated with intravenous antibiotics followed by clinical improvement, but no effect on CRP level. Repeated pleural fluid analysis showed exudative effusion (pleural fluid LDH/plasma LDH-ratio > 0,60, normal leukocyte differential count, no malignant cells (analysed twice, 28mL and 40mL respectively) and no bacterial growth (cultured four times). Throat swab for mycoplasma pneumonia, Chlamydophila pneumonia, Chlamydophila psittaci, Respiratory Syncytial virus, Influenza A and B and Covid-19 and investigations for Legionella and pneumococcus antigen in the urine were all negative. Chest ultrasound confirmed a septated left-sided pleural fluid. Treatment with intrapleural fibrinolytics was started via a 14 Fr drain. Contrast enhanced CT showed left-sided pleural thickening without contrast-enhancement, moderate left-sided loculated pleural effusion, an enlarged 12mm mediastinal lymph node at station 8 and an osteolytic process in Th10 (shown in Fig. 1 ). Magnetic Resonance Imaging (MRI) of the spine revealed multiple lesions compatible with metastases without spinal cord affection. A Flourine-18-labeled fluorodeoxyglucose ( 18 F-FDG)-positron emission tomography (PET)-CT showed increased FDG uptake in the left pleura, multiple metabolic active lymph nodes in the cervical and mediastinal region and under the diaphragm and increased FDG uptake in the skeleton (shown in Fig. 2 ). Disseminated malignant mesothelioma was suspected. Ultrasound-guided closed pleural biopsy, 18G, from the PET-positive, left dorsal parietal pleura showed malignant cells, some with intra-cytoplasmic vacuoles, and immunohistochemistry positive reaction to CD31 and CD34, suggesting pleural epithelioid hemangioendothelioma (shown in Fig. 3 ). The patient was referred for oncological treatment, but his clinical condition worsened rapidly, and he died before treatment could be started. Epithelioid hemangioendothelioma is a rare vascular tumor (estimated global prevalence is < 1:1,000,000 (2)), which typically arises in liver(21%), both liver and lung (14%), lung exclusively (12%) or bone exclusively (14%) (3, 4) , whereas pleural effusion only has been described in ~4% of the patients (5). Histological characteristics include epithelioid cells with intra-cytoplasmic vacuoles and a prominent myxoid and hyalinised or condroid stroma (shown in Fig. 3 ) (6). Immunohistochemistry is often positive for the endothelial markers CD31 (shown in Fig. 3 ) and CD34 (7) . Generally, epithelioid hemangioendothelioma is more prevalent in females (around 60% (5, 8) ) and in young adults, but can occur over abroad age range from 2 to 82 years (5, 8) . The 5year survival rate is 60-73% (5, 9) . In contrast, pleural epithelioid hemangioendothelioma (PEH) is most frequently seen in elderly men (10), and is associated with a 5-year survival rate of 2% (median survival <1 year) (9) . Symptoms include chest pain, dyspnea, productive cough and fever, thus symptoms of pleural inflammation or infection (5, 9, 10) . Typical CT findings are smallmoderate, unilateral pleural effusions and pleural thickening (10). The diagnostic yield of pleural cytology has only been considered in two case reports involving three patients: one with negative cytology, one with atypical cells and one with undifferentiated malignancy (10, 11). We found no malignant cells in repeated cytological analysis of the pleural fluid. Treatment options of PEH are casuistically reported, and include pleural decortication, chemotherapy, immune therapy and best supportive care (10, [12] [13] [14] . In our case story the episode of a contralateral pleural effusion four years earlier made us consider the possibility of a connection between the episodes, but we ended up concluding that they were J o u r n a l P r e -p r o o f independent of each other. Pleural effusions are not uncommon (15) and a contralateral PEH four years earlier is contradicted by the dismal prognosis of this disease and pleural malignancy in general (1, 16) . PEH should be remembered as a differential diagnosis in patients with pleural thickening and signs of empyema. J o u r n a l P r e -p r o o f Epidemiology: why is pleural disease becoming more common Hepatic malignant epithelioid hemangioendothelioma: a case report and review of the literature. The American surgeon Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions. The American journal of surgical pathology New Insights about Pulmonary Epithelioid Hemangioendothelioma: Review of the Literature and Two Case Reports. Case reports in radiology Imaging findings in epithelioid hemangioendothelioma Prognostic factors and surgical indications of pulmonary epithelioid hemangioendothelioma: a review of the literature An older patient with bilateral non-traumatic haemothoraces Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment. Current treatment options in oncology Primary pleural epithelioid hemangioendothelioma (EHE)--two cases and review of the literature. The clinical respiratory journal Pleural epithelioid hemangioendothelioma. Yonsei medical journal Epidemiology: why is pleural disease becoming more common Incidence of malignancy and survival in patients with idiopathic pleuritis The authors thank the patient and relatives for allowing presentation as a clinical case. Written informed consent was obtained from the patient. J o u r n a l P r e -p r o o f The Authors have no conflicts of interest to declare. No funding has been received for the study. All authors contributed to the manuscript writing and approved the submission of the final manuscript. KF stood for drafting. All authors undertook critical revision. Correspondence should be addressed to KF. All authors read and approved the final manuscript.